From relapse to remission: What an indigenous CAR-T therapy signals for India’s cancer market
When Dr Arora was diagnosed with non-Hodgkin’s lymphoma in 2022, she crossed overnight from a practising doctor to a patient. Her recovery with ImmunoACT’s indigenous CAR-T therapy now sits at the intersection of medicine and…